Eurofins Genomics LLC

Louisville, KY Part of Eurofins Genomics US Holdings, LLC

UEI
GE75H6G8HKM5
CAGE
3YJT4
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
12621 Plantside Dr, Louisville, KY 40299, USA
Website
eurofinsgenomics.com
Founded
1986
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Eurofins Genomics LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Nichd: custom oligo synthesis (synthesis). Contract · 75N98026P01770 Office of Logisitics and Acquisition Operations $2,000
UAC-0000014079 - nutritional testing - ellen turner - eurofins microbiology laboratories INC. Contract · 1232SA26P0191 Central Program Planning Coordination and Support $9,695
Custom oligos used to perform critical experiments for the lab for ongoing research that started prior to january 20,… Contract · 75N95A25F00003 National Institute of Neurological Disorders and Stroke $7,500
Custom oligos Contract · 75N95A25F00002 National Institute of Neurological Disorders and Stroke $7,500
Sequencing services Contract · 75N95A25F00001 National Institute of Neurological Disorders and Stroke $10,000

About Eurofins Genomics LLC

Written by GovTribe AI ·

Eurofins Genomics LLC, a for-profit manufacturer of genomic research materials and laboratory services based in Louisville, Kentucky, operates as a prime contractor delivering custom oligonucleotides, DNA sequencing, plasmid preparation, and pandemic preparedness supplies to federal agencies on a full-and-open (non-set-aside) basis. The company is a subsidiary of foreign-owned Eurofins Genomics US Holdings, LLC, with Mwg-Biotech, Inc. as a named subsidiary within the corporate structure.

Eurofins competes across a distributed customer base concentrated in civilian health and research agencies. The top five customer organizations by award count account for 31% of recent awards, led by the National Institute of Allergy and Infectious Diseases (11 awards, $49 thousand combined potential value), the Department of the Navy Bureau of Medicine and Surgery (10 awards, $417 thousand), and the NIH Office of the Director (9 awards, $106 thousand). By dollar value, the picture shifts notably: the NIH Office of Logistics and Acquisition Operations anchors a $10 million Blanket Purchase Agreement signed in May 2024 (coverage: 27% of combined potential value across all customers), followed by the CDC Pittsburgh facility ($523 thousand across three awards) and the Navy Bureau of Medicine and Surgery. This concentration split signals that Eurofins secures large-value vehicles through research logistics channels while sustaining higher-frequency, smaller-dollar work across NIH institutes and Navy labs.

Recent representative prime work includes a $24.1 million definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response in April 2023 for COVID-19 supply chain industrial base expansion (medical supplies and equipment), transitioned from a prior Department of Defense/Air Force contract; a $10 million single-award BPA with NINDS effective May 2024 for biological materials and sequencing services; a $185 thousand CDC purchase order for good laboratory practice-grade sequencing of plasmids for circulating vaccine-derived poliovirus strains (September 2023); and multiple $7,500 to $10,000 BPA calls from NINDS for custom oligonucleotides and sequencing services (December 2024–April 2026). Performance sites include Eurofins facilities in Jeffersontown and Neffsville, Pennsylvania, and Louisville, Kentucky.

Eurofins' primary vehicle positions center on three NIH-managed BPAs: HHSN263200500062535B (10 task orders, $42 thousand combined value), HHSN263201500064B (8 task orders, $25 thousand), and a Navy logistics BPA 75N98024A00124 (4 task orders, $35 thousand). The company's award distribution is clustered in in-vitro diagnostic substance manufacturing (31 awards) and biotechnology R&D (26 awards), with task orders concentrated under Laboratory Equipment and Supplies (52 awards) and Drugs and Biologicals (23 awards) PSC categories.

Activity has remained modest in absolute terms — two awards per year in 2021–2022, rising to seven in 2024 — with 143 total awards and $42.1 million combined potential value across 27 distinct customer agencies since 2004. Eurofins operates exclusively as a prime (100% of awards), with no subcontract work in the source data. The company obligated $32.3 million (77% of combined potential value), indicating strong follow-through on awarded work.

Quick answers

What is Eurofins Genomics LLC's UEI?

Eurofins Genomics LLC's Unique Entity ID (UEI) in SAM.gov is GE75H6G8HKM5.

What is Eurofins Genomics LLC's CAGE code?

Eurofins Genomics LLC's CAGE code is 3YJT4.

What is Eurofins Genomics LLC's primary NAICS code?

Eurofins Genomics LLC's primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Eurofins Genomics LLC located?

Eurofins Genomics LLC's physical address in SAM.gov is 12621 Plantside Dr, Louisville, KY 40299, USA.

Is Eurofins Genomics LLC registered in SAM.gov?

Yes. Eurofins Genomics LLC's SAM.gov registration is active through April 21, 2027.

Who is Eurofins Genomics LLC's parent company?

Eurofins Genomics LLC is part of Eurofins Genomics US Holdings, LLC.

What is Eurofins Genomics LLC's most recent federal award?

Eurofins Genomics LLC's most recent federal contract award is Nichd: custom oligo synthesis (synthesis) (75N98026P01770), from Office of Logisitics and Acquisition Operations, on September 23, 2026.

On GovTribe

See Eurofins Genomics LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login